ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 87 filers reported holding ALLOVIR INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $120,348 | -13.6% | 159,423 | -22.2% | 0.00% | – |
| Q4 2023 | $139,341 | -61.4% | 204,974 | +22.2% | 0.00% | – |
| Q3 2023 | $360,622 | -31.3% | 167,731 | +8.6% | 0.00% | – |
| Q2 2023 | $525,300 | +13.0% | 154,500 | +30.9% | 0.00% | – |
| Q1 2023 | $464,869 | -17.1% | 117,987 | +7.9% | 0.00% | – |
| Q4 2022 | $561,033 | -34.9% | 109,363 | -0.1% | 0.00% | – |
| Q3 2022 | $862,000 | +136.8% | 109,423 | +17.5% | 0.00% | – |
| Q2 2022 | $364,000 | -38.7% | 93,144 | +5.7% | 0.00% | – |
| Q1 2022 | $594,000 | -47.9% | 88,087 | 0.0% | 0.00% | – |
| Q4 2021 | $1,140,000 | -48.4% | 88,087 | -0.0% | 0.00% | – |
| Q3 2021 | $2,208,000 | +49.0% | 88,097 | +17.3% | 0.00% | – |
| Q2 2021 | $1,482,000 | -24.7% | 75,073 | -10.8% | 0.00% | – |
| Q1 2021 | $1,969,000 | -24.2% | 84,161 | +24.5% | 0.00% | -100.0% |
| Q4 2020 | $2,598,000 | +79.3% | 67,577 | +28.2% | 0.00% | – |
| Q3 2020 | $1,449,000 | – | 52,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,323,371 | $15,683,000 | 0.66% |
| GMT CAPITAL CORP | 1,138,070 | $7,682,000 | 0.48% |
| RA Capital Management | 1,440,525 | $9,724,000 | 0.21% |
| Redmile Group, LLC | 823,371 | $5,558,000 | 0.17% |
| Samsara BioCapital, LLC | 82,336 | $556,000 | 0.14% |
| Woodline Partners LP | 1,087,093 | $7,338,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 93,166 | $629,000 | 0.08% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,532 | $7,719,000 | 0.04% |
| Virtus ETF Advisers LLC | 10,463 | $71,000 | 0.03% |
| PDT Partners, LLC | 30,198 | $204,000 | 0.02% |